InterCure Ltd.
INCR
$1.10
$0.065.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.40% | 14.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.40% | 14.75% | |||
| Cost of Revenue | 3.40% | 65.59% | |||
| Gross Profit | 3.51% | -98.73% | |||
| SG&A Expenses | 3.40% | 40.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 3.39% | 382.98% | |||
| Total Operating Expenses | 3.40% | 82.68% | |||
| Operating Income | -3.40% | -1,440.29% | |||
| Income Before Tax | -3.40% | -1,836.73% | |||
| Income Tax Expenses | -3.39% | -1,398.97% | |||
| Earnings from Continuing Operations | -3.40% | -1,953.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 3.34% | 851.66% | |||
| Net Income | -3.40% | -2,023.90% | |||
| EBIT | -3.40% | -1,440.29% | |||
| EBITDA | -3.40% | -619.72% | |||
| EPS Basic | -3.41% | -2,276.19% | |||
| Normalized Basic EPS | -3.41% | -4,635.48% | |||
| EPS Diluted | -3.41% | -2,276.19% | |||
| Normalized Diluted EPS | -3.41% | -4,635.48% | |||
| Average Basic Shares Outstanding | 0.00% | -10.76% | |||
| Average Diluted Shares Outstanding | 0.00% | -10.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||